Mechanism of action of aminoglutethimide in breast cancer

AI implementation in the UK landscape: Knowledge of AI governance, perceived challenges and opportunities, and ways forward for radiographers.

Radiography (London, England : 1995)·2024

Correction: eEF-2 kinase is a critical regulator of Warbrug effect through controlling PP2A-A synthesis.

Oncogene·2018

Machine learning "red dot": open-source, cloud, deep convolutional neural networks in chest radiograph binary normality classification.

Clinical radiology·2018

A physiologically relevant 3D collagen-based scaffold-neuroblastoma cell system exhibits chemosensitivity similar to orthotopic xenograft models.

Acta biomaterialia·2018

Knee pain and related health in the community study (KPIC): a cohort study protocol.

BMC musculoskeletal disorders·2017

eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis.

Oncogene·2016

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Real-Time Single Molecule Imaging Reveals Pathway-Selective Action of Aducanumab on Amyloid-β Aggregation.

Nano letters·2026

B-Cell Follicles in the Secondary Lymphatic Tissues Act as a Critical Microanatomical Niche for Sustained Viral Replication, Virus-Host Interaction and Damage During Chronic SIV Infection of Rhesus Macaques.

Journal of medical virology·2026

Vogt-Koyanagi-Harada disease: Recent perspectives.

Indian journal of ophthalmology·2026

Tripartite motif protein 32 overexpression promotes inflammation and pyroptosis in INS-1 cells via the NF-κB/NLRP3 signaling pathway under high glucose conditions.

Endokrynologia Polska·2026

Fast response in facial vitiligo monitored by non-invasive imaging during topical ruxolitinib treatment.

Dermatology reports·2026

Contextual laboratory interpretation of anti-topoisomerase I positivity in systemic sclerosis: a de-duplicated real-world analysis.

Clinical chemistry and laboratory medicine·2026

Related Experiment Videos

Mechanism of action of aminoglutethimide in breast cancer

Related Concept Videos

AI implementation in the UK landscape: Knowledge of AI governance, perceived challenges and opportunities, and ways forward for radiographers.

Correction: eEF-2 kinase is a critical regulator of Warbrug effect through controlling PP2A-A synthesis.

Machine learning "red dot": open-source, cloud, deep convolutional neural networks in chest radiograph binary normality classification.

A physiologically relevant 3D collagen-based scaffold-neuroblastoma cell system exhibits chemosensitivity similar to orthotopic xenograft models.

Knee pain and related health in the community study (KPIC): a cohort study protocol.

eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Real-Time Single Molecule Imaging Reveals Pathway-Selective Action of Aducanumab on Amyloid-β Aggregation.

B-Cell Follicles in the Secondary Lymphatic Tissues Act as a Critical Microanatomical Niche for Sustained Viral Replication, Virus-Host Interaction and Damage During Chronic SIV Infection of Rhesus Macaques.

Vogt-Koyanagi-Harada disease: Recent perspectives.

Tripartite motif protein 32 overexpression promotes inflammation and pyroptosis in INS-1 cells via the NF-κB/NLRP3 signaling pathway under high glucose conditions.

Fast response in facial vitiligo monitored by non-invasive imaging during topical ruxolitinib treatment.

Contextual laboratory interpretation of anti-topoisomerase I positivity in systemic sclerosis: a de-duplicated real-world analysis.

Related Experiment Videos

Mechanism of action of aminoglutethimide in breast cancer

Related Concept Videos

Related Articles